Anchun International Enters Strategic Collaboration Agreement; Shares Rise 14%
Anchun International (SGX:BTX) entered into a strategic partnership agreement with Stamicarbon through its wholly owned subsidiary, Hunan Anchun Advanced Technology, according to a filing with the Sin
MT NewswiresApr 23 22:05 ET
Anchun International Buys Back More Shares
Anchun International Holdings (SGX:BTX) repurchased an additional 100,000 shares in the open market for SG$30,094, or SG$0.30 apiece, according to a Friday bourse filing. The engineering services comp
MT NewswiresDec 4, 2023 00:45 ET
Why You Might Be Interested In Anchun International Holdings Ltd. (SGX:BTX) For Its Upcoming Dividend
It looks like Anchun International Holdings Ltd. (SGX:BTX) is about to go ex-dividend in the next four days. The ex-dividend date occurs one day before the record date which is the day on which share
Simply Wall StApr 27, 2023 18:42 ET
Anchun International Buys Back Shares
04:54 AM EST, 11/25/2022 (MT Newswires) -- Anchun International (SGX:BTX) repurchased another 50,000 shares in the market on Thursday for about SG$15,550 ($11,311), or SG$0.31 per share. As of Nov. 24
MT NewswiresNov 25, 2022 04:56 ET
Shareholders Can Be Confident That Anchun International Holdings' (SGX:BTX) Earnings Are High Quality
Even though Anchun International Holdings Ltd.'s (SGX:BTX) recent earnings release was robust, the market didn't seem to notice. Investors are probably missing some underlying factors which are encou
Simply Wall StAug 17, 2022 18:20 ET
Anchun International Back in Black as H1 Revenue Soars 202%
07:41 AM EDT, 08/10/2022 (MT Newswires) -- Anchun International (SGX:BTX) returned to profitability in the first half of the year, thanks to a 202% surge in revenue during the period, according to a W
MT NewswiresAug 10, 2022 07:42 ET
Anchun International Warns of Losses in H2, FY2021
04:30 AM EST, 02/15/2022 (MT Newswires) -- Anchun International (SGX:BTX) expects to post a loss in the six months and 12 months ended Dec. 31, 2021, primarily due to higher research and development
MT NewswiresFeb 15, 2022 04:36 ET
Brooklyn ImmunoTherapeutics Names Howard Federoff CEO
Brooklyn ImmunoTherapeutics Names Howard Federoff CEO
Benzinga Real-time NewsApr 6, 2021 07:13 ET
Brooklyn ImmunoTherapeutics shares are trading higher after multiple Form 3 filings late Monday night showed new stakes by insiders. When an insider buys shares, the market may perceive it as a sign o
Brooklyn ImmunoTherapeutics shares are trading higher after multiple Form 3 filings late Monday night showed new stakes by insiders. When an insider buys shares, the market may perceive it as a sign o
BenzingaApr 6, 2021 06:43 ET
No Data
No Data